Continuous intraarterial infusion of protease inhibitors in acute pancreatitis

Drugs of Today

Volumn 37, Issue 3, 2001, Pages 151-158

  Komoriyama, H ^a   Tanaka, I ^a   Ikezawa, H ^a   Kanasugi, K ^a   Hagiwara, M ^a   Yamaguchi, S ^a  

^a ST MARIANNA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SYNTHESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; JAPAN; MALE; PANCREATITIS; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035047721     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2001.37.3.614850     Document Type: Review

References (44)

1. Aetiology and pathogenesis of pancreatitis (current concepts)
2. Sur le trypsinogene et la trypsine de porc
3. The therapy of pancreatitis
4. Protective effect of proteinase inhibitors in acute necrotizing pancreatitis: An experimental study
5. Effect of a new trypsine inhibitor in the therapy of experimental pancreatitis
6. Pancreatitis -Intrapancreatic proteolytic trypsin activity
7. Experimental pancreatitis: Use of a new antiproteolytic substance Trasylol
8. Experimental studies on prevention of fatal pancreatitis
9. Treatment of acute pancreatitis with Trasylol: Report of a controlled therapeutic trial
10. Trasylol in acute pancreatitis
11. Death from acute pancreatatis. MRC multicentre trial of glucagon and aprotinin
12. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis
13. A controlled trial of Trasylol in the treatment of acute pancreatitis
14. The activation of trypsinogen by cathepsin B
15. Pancreatitis: The role of lysosomes
16. Inhibition of tryptic activity by various synthetic inhibitors
17. Inhibitory effects of omega-guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin
18. New synthetic inhibitors of Clr, Cl esterase, thrombin, plasmin, kallikrein and trypsin
19. Pharmacological studies of FUT-175, nafamstat mesilate. Inhibition of protease activity in in vitro and in vivo experiments
20. Pharmacological studies of FUT-175, nafamostat mesilate. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats
21. Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats
22. Beneficial effects of cholecystokinin-recepter blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice
23. Effect of protease inhibitor FUT-175 on acute hemorrhagic pancreatitis in mice
24. Gabexate mesilate in human pancreatitis
25. Effectiveness of gabexate mesilate in acute pancreatitis: A metaanalysis
26. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis
27. Vascular changes of pancreatic ducts and vessels in acute necrotizing and in chronic pancreatitis in humans
28. Application of HPLC measurment of plasma concentration of gabexate mesilate
29. Local intra-arterial infusion of antienzymes in the treatment of acute pancreatitis
30. Arterial infusion of antienzymes in the treatment of experimental paccreatitis
31. Effect of continuous intraarterial infusion of trypsin inhibitor on acute experimental pancreatitis in dogs
32. Continuous arterial infusion of protease inhibitor as a new treatment for severe acute pancreatitis
33. Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction
34. Therapeutic effects of continuous intraarterial antibiotic infusion in prevention of pancreatic infection in experimental acute necrotizing pancreatitis
35. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis
36. Bacterial contamination of pancreatic necrosis. A prospective clinical study
37. The role of the gut in the development of sepsis in acute pancreatitis
38. Pathogenesis of pancreatic sepsis
39. Human pancreatic tissue concentration of bactericidal antibiotics
40. Effect of antibiotics on endotoxin release from Gram-negative bacteria
41. Effects of FOY on serum amylase after endoscopic retrograde cholangiopancreatography
42. Effects of FOY on complicatioms after endoscopic retrograde cholangiopancreatography
43. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography
44. Complications of endoscopic sphincterotomy and their prevention